Summary
- Current Price
- As of today, CUE price is $0.50, up +71.39% on
- Current Price All-Time High
- CUE price is currently -98.42% below its historical high of $31.69 set on
- Market Cap
- CUE current market cap is $46M, up +3.04% over the past 365 days
- PE Ratio
- CUE PE ratio is unknown
- Revenue
- CUE current annual revenue is $27.47M, up +195.75% year-over-year
- Next Earnings
- As of today, the next earnings release for CUE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Cue Biopharma, Inc. |
| Ticker | NASDAQ: CUE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cuebiopharma.com |
| Employees | 41 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.50 | ||
| Price, 1D Change | +71.39% | |
| $46M | ||
| - | ||
| - | ||
| 1.61 | ||
| $27M | ||
| Revenue, 1Y Change | +195.75% | |
| -$0.28 | ||
| EPS, 1Y Change | +61.11% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.28 | ||
| EPS Estimate | N/A | -$0.58 |
| EPS Est. Change | N/A | -106.55% |
| $27.47M | ||
| Revenue Estimate | N/A | $1.00M |
| Revenue Est. Change | N/A | -96.36% |
| $0.50 | ||
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +696.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.76 | -$0.72 | +4.36% | |
| -$0.40 | -$0.28 | +29.80% | |
| -$0.58 | N/A | -106.55% | |
| -$0.60 | N/A | -113.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.41M | $9.29M | -1.31% | |
| $6.50M | $27.47M | +322.55% | |
| $1.00M | N/A | -96.36% | |
| $1.00M | N/A | -96.36% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -30.18% | ||
| -84.55% | ||
| +3.04% | ||
| -67.36% | ||
| +195.75% | ||
| +2,105.75% | ||
| +61.11% | ||
| +81.12% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.50 | ||
| $0.57 | ||
| SMA 200 vs Price | +12.59% | |
| $0.29 | ||
| SMA 50 vs Price | -42.63% | |
| 1.61 | ||
| $0.06 | ||
| 78.03 | ||
| 431.51% | ||
| 128.61% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $27.47M | ||
| -$0.28 | ||
| $23.99M | ||
| 87.33% | ||
| -$26.52M | ||
| -96.56% | ||
| -$26.60M | ||
| -96.85% | ||
| -$23.04M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.16 | ||
| 2.74 | ||
| 2.74 | ||
| - | ||
| 4 | ||
| -11.05 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.67 | ||
| 1.73 | ||
| -1.03 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $26.43M | ||
| $27.14M | ||
| $43.15M | ||
| $36.98M | ||
| $16.71M | ||
| $13.49M | ||
| $4.20M | ||
| $1.91M | ||
| $3.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $54.07M | ||
| $50.51M | ||
| $3.48M | ||
| $0.00 | ||
| $3.48M | ||
| $0.00 | ||
| $500.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$21.69M | ||
| $75.00K | ||
| $26.29M | ||
| $177.00K | ||
| -$21.86M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| LUCID CAPITAL MARKETS | ||
| Citizens Capital Markets | → | |
| Stifel | → | |
| Piper Sandler | → | |
| JMP Securities | → | |
| Stifel | → | |
| Oppenheimer | → | |
| Piper Sandler | → | |
| Jefferies | ||
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with CUE
FAQ
What is the ticker symbol for Cue Biopharma, Inc.?
The ticker symbol for Cue Biopharma, Inc. is NASDAQ:CUE
Does Cue Biopharma, Inc. pay dividends?
No, Cue Biopharma, Inc. does not pay dividends
What sector is Cue Biopharma, Inc. in?
Cue Biopharma, Inc. is in the Healthcare sector
What industry is Cue Biopharma, Inc. in?
Cue Biopharma, Inc. is in the Biotechnology industry
What country is Cue Biopharma, Inc. based in?
Cue Biopharma, Inc. is headquartered in United States
When did Cue Biopharma, Inc. go public?
Cue Biopharma, Inc. initial public offering (IPO) was on January 2, 2018
Is Cue Biopharma, Inc. in the S&P 500?
No, Cue Biopharma, Inc. is not included in the S&P 500 index
Is Cue Biopharma, Inc. in the NASDAQ 100?
No, Cue Biopharma, Inc. is not included in the NASDAQ 100 index
Is Cue Biopharma, Inc. in the Dow Jones?
No, Cue Biopharma, Inc. is not included in the Dow Jones index
When was Cue Biopharma, Inc. last earnings report?
Cue Biopharma, Inc.'s most recent earnings report was on May 15, 2025
When does Cue Biopharma, Inc. report earnings?
The date for Cue Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CUE Official Website www.cuebiopharma.com
- CUE Profile on Yahoo Finance finance.yahoo.com/quote/CUE
- CUE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cue